Destination
1 in 5 U.S adults say they've taken Ozempic or similar drugs, survey finds

Another one in five adults who aren’t using the GLP-1 drugs said they are interested in taking one for weight loss [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
The most popular social media platform among US adults isn't Instagram or TikTok

Social media is an overwhelming part of our lives these days, but the Pew Research Center provided an in-depth look at just how much we rely on these platforms. In a 2025 report that looks at social m [...]

Match Score: 65.51

thenextweb
Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 62.54

Destination
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 57.80

venturebeat
43% of AI-generated code changes need debugging in production, survey finds

The software industry is racing to write code with artificial intelligence. It is struggling, badly, to make sure that code holds up once it ships.A survey of 200 senior site-reliability and DevOps le [...]

Match Score: 53.69

venturebeat
Most enterprises can't stop stage-three AI agent threats, VentureBeat survey finds

A rogue AI agent at Meta passed every identity check and still exposed sensitive data to unauthorized employees in March. Two weeks later, Mercor, a $10 billion AI startup, confirmed a supply-chain br [...]

Match Score: 52.61

venturebeat
98% of market researchers use AI daily, but 4 in 10 say it makes errors — revealing a major trust problem

Market researchers have embraced artificial intelligence at a staggering pace, with 98% of professionals now incorporating AI tools into their work and 72% using them daily or more frequently, accordi [...]

Match Score: 50.35

Destination
Engadget Podcast: iPhone 16e review and Amazon's AI-powered Alexa+

The keyword for the iPhone 16e seems to be "compromise." In this episode, Devindra chats with Cherlynn about her iPhone 16e review and try to figure out who this phone is actually for. Also, [...]

Match Score: 48.41

venturebeat
Wall Street is debating the AI buildout. Enterprises just answered: 86% say their GPUs run at half capacity or less

Enterprise companies are running AI agents ahead of the controls needed to manage them — and they deployed that way knowingly. That is the central finding from VentureBeat Research's June surve [...]

Match Score: 45.37

Destination
Here's how much Ozempic and similar drugs have soared in popularity since 2018

The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.R [...]

Match Score: 41.30